Hedge fund Starboard reveals Q2 strategy shifts: new stakes in TripAdvisor & iShares Russell 2000 ETF, boosted Salesforce & Pfizer holdings, trimmed ...

Activist Starboard Value, one of the first investors to publicly push Salesforce to make changes three years ago, increased ...

Most important is anti-blood-clot medicine Eliquis, which is due to lose patent exclusivity in 2026. Eliquis emerged last year as Pfizer’s top-performing drug, having grown rapidly to bring in $7.4bn ...

Dividend stocks are a time-tested way to retire or protect your portfolio if you are already retired. Their yield can give ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. The FLOTILLA Study, officially titled ‘ENCORAFENIB/BINIMETINIB MASTER ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a clinical study titled ‘A PHASE 2, RANDOMIZED, ...

Pfizer Inc. just made headlines by acquiring a promising biotech firm. The strategic move aims to enhance Pfizer's portfolio ...

The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...

The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...

Meanwhile, the BSE HEALTHCARE index is at 44,846.1 (up 0.6%). Among the top gainers in the BSE HEALTHCARE index today are Aurobindo Pharma (up 3.0%) and ALEMBIC PHARMA (up 2.4%). MAX HEALTHCARE ...

Pfizer climbed 5.16% to Rs 5,390.30 after posting a strong performance in the June quarter. Revenue from operations stood at Rs 603.05 crore, up 7.14% YoY from Rs 562.86 crore and 1.88% higher than Rs ...

At the same time, more than half of the US-listed stocks covered by Morningstar that reported earnings as of Aug. 11 beat ...